Search

everythinglearnresearchcommunity

for

Search:↓

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Post-finasteride syndrome's existence is uncertain; more research needed.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hair from balding and non-balding areas regrows similarly on mice.

Antiandrogen therapy helps treat genetic hair loss.

Finasteride helps reduce heart enlargement in heart failure patients.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Androgenetic alopecia in women needs more research and better management strategies.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Spironolactone might lower the chance of getting rosacea.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Hair loss needs more research for better treatments.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.